Despite the many outstanding favorable results achieved in the treatment of
hypertension, several unmet goals of antihypertensive therapy remain, such
as better blood pressure control, greater protection against the organ dam
age associated with hypertension, better tolerability, and ultimately a mor
e effective prevention of cardiovascular disease. These unmet goals are the
reasons why new antihypertensive drugs are synthesized and tested in the c
linical practice.
This paper briefly mentions the goals of new antihypertensive agents and ex
amines the main pharmacological and clinical features of new classes of ant
ihypertensive drugs, such as angiotensin II receptor blockers, central agen
ts, vasopeptidase inhibitors, and endothelin antagonists. The results of ex
perimental and clinical studies with these new drugs are reviewed, emphasiz
ing some advantages and potential disadvantages of these drugs compared wit
h traditional antihypertensive drugs, Curr Opin Cardiol 1999, 14:375-380 (C
) 1999 Lippincott Williams & Wilkins, Inc.